{"name": "Diagnoplex",
 "permalink": "diagnoplex",
 "crunchbase_url": "http://www.crunchbase.com/company/diagnoplex",
 "homepage_url": "http://www.diagnoplex.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2005,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@diagnoplex.com",
 "phone_number": "+41 21 989 20 00",
 "description": "molecular cancer diagnostics",
 "created_at": "Tue Jun 16 08:28:36 UTC 2009",
 "updated_at": "Sat Jun 08 03:45:01 UTC 2013",
 "overview": "\u003Cp\u003EDiagnoplex has been founded in 2005 supported by seed financing fron the Novartis Forschungsstiftung, Swiss Confederation CTI project, Canton de Vaud FIT and the Gebert R\u00c3\u00bcf Stiftung. The company has performed a 140 patient prospective pilot study demonstrating technical and clinical feasibility of its colorectal cancer screening test COLOX as well as its high sensitivity and specificity.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       40],
      "assets/images/resized/0004/8811/48811v1-max-150x150.jpg"],
     [[250,
       66],
      "assets/images/resized/0004/8811/48811v1-max-250x250.jpg"],
     [[326,
       87],
      "assets/images/resized/0004/8811/48811v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$9.7M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.bio-medicine.org/biology-technology-1/Diagnoplex-Closes-CHF10-Million--28-248-3-Million-29-Series-A-Financing-9592-1/",
    "source_description": "Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing",
    "raised_amount": 8300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 12,
    "funded_day": 13,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novartis Venture Funds",
         "permalink": "novartis-ventures",
         "image":
          {"available_sizes":
            [[[150,
               14],
              "assets/images/resized/0004/4137/44137v1-max-150x150.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-250x250.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "NeoMed",
         "permalink": "neomed",
         "image":
          {"available_sizes":
            [[[150,
               55],
              "assets/images/resized/0006/1662/61662v3-max-150x150.png"],
             [[151,
               56],
              "assets/images/resized/0006/1662/61662v3-max-250x250.png"],
             [[151,
               56],
              "assets/images/resized/0006/1662/61662v3-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2013/06/diagnoplex-secures-1-3m-swiss-francs.html",
    "source_description": "Diagnoplex Secures 1.3M Swiss Francs",
    "raised_amount": 1400000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 6,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Debiopharm Diagnostics SA",
         "permalink": "debiopharm-diagnostics-sa",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "NeoMed",
         "permalink": "neomed",
         "image":
          {"available_sizes":
            [[[150,
               55],
              "assets/images/resized/0006/1662/61662v3-max-150x150.png"],
             [[151,
               56],
              "assets/images/resized/0006/1662/61662v3-max-250x250.png"],
             [[151,
               56],
              "assets/images/resized/0006/1662/61662v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Initiative Capital Romandie",
         "permalink": "initiative-capital-romandie-2",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "Chemin de Vulliette 4, CH-1000 Lausanne 25",
    "address2": "",
    "zip_code": "CH-1000",
    "city": "Lausanne",
    "state_code": null,
    "country_code": "CHE",
    "latitude": 46.5567716,
    "longitude": 6.6833176}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        148],
       "assets/images/resized/0004/8816/48816v1-max-150x150.jpg"],
      [[250,
        246],
       "assets/images/resized/0004/8816/48816v1-max-250x250.jpg"],
      [[450,
        444],
       "assets/images/resized/0004/8816/48816v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}